MERCURI, NICOLA BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 71.186
EU - Europa 5.323
AS - Asia 3.180
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 25
AF - Africa 3
Totale 79.786
Nazione #
US - Stati Uniti d'America 71.134
SG - Singapore 1.597
IT - Italia 988
CN - Cina 983
IE - Irlanda 892
UA - Ucraina 869
DE - Germania 680
RU - Federazione Russa 495
KR - Corea 426
FR - Francia 302
GB - Regno Unito 276
SE - Svezia 264
FI - Finlandia 205
PL - Polonia 145
CA - Canada 44
CZ - Repubblica Ceca 39
BE - Belgio 38
JP - Giappone 38
NL - Olanda 31
IN - India 28
EU - Europa 27
BR - Brasile 26
AU - Australia 22
KG - Kirghizistan 19
VN - Vietnam 18
RO - Romania 17
CH - Svizzera 16
UZ - Uzbekistan 10
DK - Danimarca 9
ES - Italia 9
HK - Hong Kong 9
IR - Iran 7
PT - Portogallo 7
AT - Austria 6
BD - Bangladesh 6
CL - Cile 6
AL - Albania 5
GR - Grecia 5
HU - Ungheria 5
MX - Messico 5
NO - Norvegia 5
PH - Filippine 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
TH - Thailandia 4
AR - Argentina 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
DM - Dominica 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CR - Costa Rica 1
GE - Georgia 1
ID - Indonesia 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 79.786
Città #
Woodbridge 19.260
Wilmington 18.992
Houston 17.515
Fairfield 2.882
Ann Arbor 1.548
Singapore 1.408
Chandler 1.369
Ashburn 1.312
Seattle 1.121
Cambridge 946
Dublin 792
Jacksonville 742
Medford 596
Santa Clara 397
Rome 390
Beijing 356
Dearborn 351
New York 305
Lawrence 277
Zhengzhou 254
Menlo Park 169
San Diego 134
Kraków 133
Moscow 114
Norwalk 82
Milan 81
Shanghai 81
London 54
Munich 53
Redwood City 53
Mountain View 52
Seoul 45
Boardman 43
Mülheim 43
Nanjing 43
Palo Alto 42
Brussels 38
Brno 36
Detroit 35
Helsinki 33
Hefei 32
University Park 32
Verona 31
Council Bluffs 29
Phoenix 29
Falls Church 28
Durham 27
Guangzhou 27
Toronto 27
Engelhard 26
Kilburn 22
San Jose 22
Washington 21
Creede 20
Kunming 20
Redmond 19
San Francisco 18
Daejeon 16
Dong Ket 16
Los Angeles 15
Philadelphia 15
São Paulo 15
Wuhan 15
Saint Petersburg 14
San Mateo 14
Chicago 13
Monmouth Junction 13
Naples 13
Pune 13
Indiana 12
Turin 12
Fuzhou 11
Hangzhou 11
Nuremberg 11
Amsterdam 10
Garden City 10
Hounslow 10
Montesilvano Marina 10
Nanchang 10
Tokyo 10
Lappeenranta 9
Chengdu 8
Chongqing 8
Genoa 8
Mcallen 8
Palermo 8
Pisa 8
Roebling 8
Warsaw 8
Frankfurt am Main 7
Hebei 7
Jinan 7
Prescot 7
Cagliari 6
Changsha 6
Hanover 6
Hong Kong 6
Kyiv 6
New Bedfont 6
Sacramento 6
Totale 73.039
Nome #
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 473
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 453
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 452
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 448
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 446
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 443
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 441
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 439
Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory 437
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 436
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 433
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 433
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 432
Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion 432
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation 431
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro 430
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 429
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 425
The Blockade of K+-ATP channels has neuroprotective effects in an in vitro model of brain ischemia 423
Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR 422
The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus 420
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 420
A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation 419
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 418
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 418
Inhibition of hippocampal plasticity in rats performing contrafreeloading for water under repeated administrations of pramipexole 418
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP 414
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 412
Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis 412
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 411
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 410
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 410
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study. 409
Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro 407
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 407
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS 406
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 406
Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis 405
Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism 405
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 405
Synaptic plasticity in the basal ganglia: a similar code for physiological and pathological conditions 403
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy 403
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 403
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons 403
Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra 402
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 402
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 402
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 402
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 401
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 400
Effects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure 399
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 398
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 398
Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 398
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease 398
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study 397
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 396
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 396
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 396
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions 395
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 395
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 395
Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/-) -3,4-Methylenedioxymethamphetamine (MDMA-"Ecstasy") 395
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 395
Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons 393
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 393
N-ethyl lidocaine (QX-314) protects striatal neurons against ischemia: an in vitro electrophysiological study 393
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 393
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility 392
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 392
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 392
Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia 392
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 392
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 391
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice 391
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis 391
Familiar trajectories facilitate the interpretation of physical forces when intercepting a moving target 390
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 389
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 389
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine 388
Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate 388
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 387
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 386
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 386
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 383
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 383
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 383
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta 383
Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease 383
Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation 382
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons 382
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals 381
Cu/Zn-superoxide dismutase (GLY93-->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture 380
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 380
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 380
Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism 380
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 379
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 379
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 378
An electrophysiological analysis of the protective effects of felbamate, lamotrigine, and lidocaine on the functional recovery from in vitro ischemia in rat neocortical slices 377
Totale 40.463
Categoria #
all - tutte 176.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015.193 0 0 0 0 1.722 2.180 1.898 2.188 2.212 1.865 1.485 1.643
2020/202113.517 1.579 1.585 1.473 1.642 1.467 1.416 1.602 1.312 333 426 518 164
2021/20223.296 153 294 153 128 108 247 393 134 162 289 227 1.008
2022/20233.702 420 297 163 415 299 826 350 285 336 57 143 111
2023/20241.682 172 51 105 53 142 390 116 191 41 112 48 261
2024/20253.437 295 1.669 788 498 187 0 0 0 0 0 0 0
Totale 81.168